Navigation Links
Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer
Date:6/10/2009

VANCOUVER, June 10 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) is pleased to announce that Livleen Kaler has been appointed Vice President Finance & Administration and Chief Financial Officer. Ms. Kaler has 10 years of financial management experience in several industries.

"Following the Annual General Meeting of the Company yesterday, the Board is pleased to recognize Livleen for her outstanding financial leadership in the first half of 2009," said S. Wayne Kay, Chief Executive Officer. "She provided strong financial oversight during our recent financing and we look forward to her continued contributions to the Company."

About Response Biomedical

Response Biomedical develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP(R) Platform for clinical and environmental applications. RAMP(R) represents a new paradigm in diagnostics that provides high sensitivity and reliable information in minutes. It is ideally suited to both point-of-care testing and laboratory use. The RAMP(R) system consists of a Reader and single-use disposable test cartridges, and has the potential to be adapted to more than 250 medical and non-medical tests currently performed in laboratories. RAMP(R) clinical tests are commercially available for the early detection of heart attack, congestive heart failure and influenza through our commercial partners, 3M Health Care and Roche, respectively.

In the non-clinical market, RAMP(R) Tests are currently provided for the environmental detection of West Nile Virus, and Biodefense applications including the rapid on-site detection of anthrax, smallpox, ricin and botulinum toxin. Several other product applications are under development. Response has achieved CE Marking for its Reader and clinical tests and its Quality Management System is registered to ISO 13485: 2003 and ISO 9001: 2000.

Response Biomedical is a publicly
'/>"/>

SOURCE Response Biomedical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Allied World U.S. Announces Strategic Response(SM) - Complimentary Service Added to General Liability Lead Umbrella Product
2. Physiological response may explain why some severely obese patients overeat
3. Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual Meeting
4. Nuvilex Offers Free Cinnergen Samples in Response to Spike in Consumer Interest
5. Obesity May Dampen Response to Asthma Meds
6. Report Gives U.S. Good Grades for Swine Flu Response
7. Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer
8. Obesity does not worsen asthma, but may reduce response to medications
9. New Data Support Use of Simple Test to Predict Endometrial Cancer Response to Chemotherapy
10. Nurse Response Partners With Healthwise to Help Consumers Make Informed Decisions on Health
11. QLT Announces Court Response to Motion to Dismiss and Removal of Case to Federal Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... NE (PRWEB) March 27, 2015 Ticket Down ... at the CenturyLink Center in Omaha, Nebraska on Friday, ... possibility that more concert dates will be added in Omaha ... of fan demand. , The Garth Brooks World Tour is ... the latest announcement that Garth Brooks and Trisha Yearwood will ...
(Date:3/27/2015)... Endure Yoga is launching WOD (Workout ... This new program matches yoga poses with functional fitness ... down. This program utilizes yoga to improve recovery, prevent ... , Karen Lefurgy, competitive athlete at CrossFit ... I started Crossfit® training, but quickly, due to time ...
(Date:3/27/2015)... 27, 2015 SMI (Silicon Microstructures, Inc.), ... has launched the SM1120 MEMS based ultra-miniature pressure sensor ... microsensor profile at only 220um x 75um provides ample ... challenging locations. With industry leading in vivo drift ... provides a broad operating pressure range from 0 to ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Operatic contenders ... of greatness on April 17th. The universally acclaimed baritone ... the 9th annual Opera Idol at The Merion in ... competition, which has drawn aspiring opera singers from around ... showcases some of the finest young talent in the ...
(Date:3/27/2015)... The 2015 Deep Market Research Report ... in-depth study on the current state of the ... on the Chinese situation. , The report provides ... classifications, applications and industry chain structure. The Glutathione ... and Chinese domestic situations including development trends, competitive ...
Breaking Medicine News(10 mins):Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 2Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 3Health News:Endure Yoga Introduces WOD Recovery Yoga 2Health News:SMI Launches Catheter Mountable Pressure Sensor 2Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Glutathione Industry International and China Market Analysis Report 2015-2020 2Health News:Glutathione Industry International and China Market Analysis Report 2015-2020 3
... in our environment that may cause breast cancer . ... linked to breast cancer has listed 216 compounds, many of ... extensive review of 900 scientific studies concerning humans and rodents ... and water that appear to be a reason behind breast ...
... toll the world over. Almost 100 million girls die every year, ... ,According to a searing report on the prejudices against women, "Because ... developing countries, where a male child remains more valued. ... child development agency - highlights the fact that two million girls ...
... Researchers at University of Southern Maine in Portland have revealed ... far the US government has been denying the possibility. ... Laboratories in New Mexico found that people exposed to DU ... ,DU is a dense, inadequately radioactive metal that is ...
... of North Carolina, Chapel Hill, have found out that middle-aged ... are at a higher risk of retinopathy than others. ... of the eye that can lead to severe vision problems ... the headache history and eye health of 10,902 men and ...
... same level of active therapeutic chemical and produces the ... the harmful toxins, according to UCSF researchers. ... of the active ingredient delta-9-tertrahydrocannibinol, or THC, are reported ... and Therapeutics." ,"We showed in a recent ...
... claimed significant success in the continuing fight to develop ... ,Thomas Pento and Roger HarrisonTwo professors say ... the spread of certain cancerous cells without damaging healthy, ... in fighting lung, prostate and pancreatic cancers without the ...
Cached Medicine News:Health News:List of Compounds That Causes Breast Cancer Identified 2Health News:Female Infanticide and Feticide Continue to Increase 2Health News:History of Migraines Linked to Increased Risk of Retinopathy 2Health News:Smokeless Cannabis Delivery Device Found Efficient and Less Toxic 2Health News:US Professors Develop Fusion Protein to Fight Cancer 2
(Date:3/27/2015)... Wis. , March 27, 2015 ... unit shipments of incontinence devices for women. ... but the most gratifying part is the hundreds ... from women whose lives have been positively impacted ... president of InControl. InControl recently released ...
(Date:3/27/2015)... 27, 2015 RnRMarketResearch.com adds ... market research report of 52 pages with latest ... intelligence library. The report "Visceral Pain - Pipeline ... therapeutic development for Visceral Pain, complete with comparative ... target, mechanism of action (MoA), route of administration ...
(Date:3/26/2015)... 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or ... on Omega-3 therapies for cardiovascular disease and overall health, ... common shares of the Corporation (the "Common Shares"). The ... of December 5 th , 2014 to March 4 ... is due on or before April 1, 2015. Interest ...
Breaking Medicine Technology:InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
... - Millennium on track to file sNDA in ... 18 Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM ) ... large, international Phase III VISTA(1) trial in,patients with ... of,VELCADE, melphalan and prednisone (VMP) demonstrated a highly ...
... 10 minutes - - Landmark Study Reported in ... 18 A landmark publication that,appeared in the Journal ... site blinded clinical study. The paper is entitled "The ... Accuracy of,Melanoma and Equivocal Melanocytic Lesions." The study, ...
Cached Medicine Technology:Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 2Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 3Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 4Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 5Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 6Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy 2Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy 3
... Produces up to 12 L/min of Type ... On Demand, The Super-Q Plus System is ... water which has been pretreated by reverse ... consistently produce ultrapure water quality which exceeds ...
... Compact System Produces Type I Water Directly from ... designed for scientists who need 5 to 15 ... not have easy access to acceptable quality pretreated ... 0.6 L/min of ultrapure (Type I) water on ...
... UniBloc weighing mechanism for speed, stability ... control, analog display modes, multiple units ... measure functions, auto print, and GLP/GMP/ISO ... from built-in clock. Touch-key calibration with ...
... size AA required). Fast, Lightweight Strain Gage ... GN, dwt, mom, dwt, tael), Specific Gravity ... Auto Print. Optional hook (321-34532-03) available for ... ordered for AC Operation of ELB. External ...
Medicine Products: